Aker BioMarine ASA (OSL:AKBM) Beneish M-Score: -3.05 (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:AKBM Aker BioMarine ASA OSL:AKBM
59 GF Score
Price kr133.20
GF Value kr63.08
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Aker BioMarine ASA Beneish M-Score?

Aker BioMarine ASA OSL:AKBM -0.15% 59 Beneish M-Score is -3.05 as of Sep. 20, 2026. GuruFocus rates OSL:AKBM with a GF Score™ of 59/100 and a GF Value™ of kr63.08 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,885 Consumer Packaged Goods companies, Aker BioMarine ASA ranks better than 85.04% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.05 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Aker BioMarine ASA's Beneish M-Score or its related term are showing as below:

OSL:AKBM' s Beneish M-Score Range Over the Past 10 Years
Min: -3.44   Med: -2.36   Max: -0.22
Current: -3.05

During the past 8 years, the highest Beneish M-Score of Aker BioMarine ASA was -0.22. The lowest was -3.44. And the median was -2.36.


Aker BioMarine ASA Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Aker BioMarine ASA's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aker BioMarine ASA Beneish M-Score Chart

Aker BioMarine ASA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial -2.56 -2.50 -2.65 -2.79 -3.06

Aker BioMarine ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.95 -2.96 -2.97 -2.99 24.32

OSL:AKBM vs KHC, GIS, MKC: Beneish M-Score Comparison

For the Packaged Foods subindustry, Aker BioMarine ASA's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aker BioMarine ASA Beneish M-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Aker BioMarine ASA's Beneish M-Score falls into.


OSL:AKBM
59GF Score
Aker BioMarine ASA OSL:AKBM
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aker BioMarine ASA Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Aker BioMarine ASA for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 30.24+0.528 * 0.875+0.404 * 0.9419+0.892 * 1.0005+0.115 * 1.0822
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9397+4.679 * -0.021725-0.327 * 1.0754
=24.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Total Receivables was kr521 Mil.
Revenue was 546.461 + 557.413 + 557.107 + 573.527 = kr2,235 Mil.
Gross Profit was 214.243 + 209.152 + 200.841 + 201.946 = kr826 Mil.
Total Current Assets was kr2,030 Mil.
Total Assets was kr3,929 Mil.
Property, Plant and Equipment(Net PPE) was kr597 Mil.
Depreciation, Depletion and Amortization(DDA) was kr179 Mil.
Selling, General, & Admin. Expense(SGA) was kr596 Mil.
Total Current Liabilities was kr781 Mil.
Long-Term Debt & Capital Lease Obligation was kr1,757 Mil.
Net Income was -50.965 + -26.266 + -55.509 + 3.029 = kr-130 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0 Mil.
Cash Flow from Operations was -58.702 + -105.062 + 113.824 + 5.574 = kr-44 Mil.
Total Receivables was kr17 Mil.
Revenue was 569.778 + 562.419 + 573.509 + 527.746 = kr2,233 Mil.
Gross Profit was 227.705 + 195.961 + 154.406 + 144.515 = kr723 Mil.
Total Current Assets was kr1,968 Mil.
Total Assets was kr3,916 Mil.
Property, Plant and Equipment(Net PPE) was kr570 Mil.
Depreciation, Depletion and Amortization(DDA) was kr190 Mil.
Selling, General, & Admin. Expense(SGA) was kr634 Mil.
Total Current Liabilities was kr750 Mil.
Long-Term Debt & Capital Lease Obligation was kr1,603 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(520.503 / 2234.507) / (17.203 / 2233.452)
=0.232939 / 0.007703
=30.24

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(722.587 / 2233.452) / (826.181 / 2234.507)
=0.323529 / 0.369738
=0.875

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2029.567 + 596.699) / 3928.514) / (1 - (1968.282 + 569.739) / 3916.324)
=0.331486 / 0.351938
=0.9419

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2234.507 / 2233.452
=1.0005

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(189.887 / (189.887 + 569.739)) / (179.23 / (179.23 + 596.699))
=0.249974 / 0.230988
=1.0822

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(595.875 / 2234.507) / (633.828 / 2233.452)
=0.26667 / 0.283789
=0.9397

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1757.441 + 780.755) / 3928.514) / ((1602.96 + 749.87) / 3916.324)
=0.646096 / 0.600775
=1.0754

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-129.71 - 0 - -44.365) / 3928.514
=-0.021725

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Aker BioMarine ASA has a M-score of 24.23 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.05 mean?
Aker BioMarine ASA (OSL:AKBM) has a Beneish M-Score of -3.05 as of Sep. 20, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Aker BioMarine ASA and its competitors. According to the industry distribution chart, Aker BioMarine ASA ranks #282 out of 1885 companies in the Consumer Packaged Goods industry, placing it in the top 15%.
Is Aker BioMarine ASA's Beneish M-Score too high?
Aker BioMarine ASA's current Beneish M-Score is -3.05. Based on the distribution chart, Aker BioMarine ASA ranks #282 out of 1885 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Aker BioMarine ASA has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's Beneish M-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Aker BioMarine ASA ranks #282 out of 1885 companies for Beneish M-Score. This places Aker BioMarine ASA in the top 15% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Consumer Packaged Goods company?
A good Beneish M-Score depends on the Consumer Packaged Goods industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Aker BioMarine ASA and its competitors. Aker BioMarine ASA's current Beneish M-Score is -3.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (OSL:AKBM) is currently considered Significantly Overvalued. The stock's GF Value™ is kr63.08, compared to a current price of kr133.20 — trading 111.2% above its estimated fair value. The current Beneish M-Score is -3.05. Aker BioMarine ASA's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Aker BioMarine ASA (OSL:AKBM), the current Beneish M-Score is -3.05 as of Sep. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aker BioMarine ASA (OSL:AKBM) Overvalued in 2026?

Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued. The current stock price of kr133.20 is trading 111.2% above its estimated GF Value™ of kr63.08. GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.

Key valuation signals for OSL:AKBM:

  • Beneish M-Score: -3.05
  • GF Value™: kr63.08 vs. price of kr133.20 (111.2% above fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the OSL:AKBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aker BioMarine ASA Business Description

Other Exchanges AKBMo:Sweden1PG:Germany
Address Oksenoyveien 10, Lysaker, NOR, 1366
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
59GF Score

Get the complete analysis for OSL:AKBM

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr133.20
Price
kr63.08
GF Value